G

GeneSystem Co Ltd
KOSDAQ:363250

Watchlist Manager
GeneSystem Co Ltd
KOSDAQ:363250
Watchlist
Price: 4 630 KRW 0.33% Market Closed
Market Cap: 32.6B KRW

Operating Margin

-2 877%
Current
Declining
by 1 834%
vs 3-y average of -1 043%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-2 877%
=
Operating Income
₩-9.9B
/
Revenue
₩345.4m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-2 877%
=
Operating Income
₩-9.9B
/
Revenue
₩345.4m

Peer Comparison

Country Company Market Cap Operating
Margin
KR
GeneSystem Co Ltd
KOSDAQ:363250
31.3B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
378.8B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
177.8B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
155.1B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.1B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.2B USD
Loading...
AU
CSL Ltd
ASX:CSL
85.7B AUD
Loading...
NL
argenx SE
XBRU:ARGX
41.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.3B USD
Loading...
No Stocks Found

Market Distribution

Lower than 99% of companies in Korea
Percentile
1st
Based on 2 615 companies
1st percentile
-2 877%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

GeneSystem Co Ltd
Glance View

Market Cap
32.6B KRW
Industry
Biotechnology

Genesystem Co., Ltd engages in providing PCR based molecular diagnostic products. The firm is engaged in the development, manufacture and sale of platform based on molecular diagnosis. The firm develops and manufactures products such as molecular diagnosis systems, biochips, test kits, and reaction reagents, among others. The firm develops in vitro diagnostic technology through immunodiagnosis technology and molecular diagnosis technology.

Intrinsic Value
451.4 KRW
Overvaluation 90%
Intrinsic Value
Price
G
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-2 877%
=
Operating Income
₩-9.9B
/
Revenue
₩345.4m
What is GeneSystem Co Ltd's current Operating Margin?

The current Operating Margin for GeneSystem Co Ltd is -2 877%, which is below its 3-year median of -1 043%.

How has Operating Margin changed over time?

Over the last 3 years, GeneSystem Co Ltd’s Operating Margin has decreased from -49.6% to -2 877%. During this period, it reached a low of -2 877% on Oct 30, 2025 and a high of -49.6% on Aug 30, 2022.

Back to Top